FindTrial
Sign In

You are suffering from autoimmune hepatitis which is a liver disease in which bodyâ??s immune system acts against its own liver cells. After confirmation of diagnosis, you will be started on treatment for same, and response to treatment will be assessed.

To assess response to steroids in patients with Autoimmune hepatitis - STAR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052679
Enrollment
90
Registered
2023-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K754- Autoimmune hepatitis

Interventions

None listed

Sponsors

TNMC and BYL Nair Ch Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: No previous medical history of AIH An International Normalized Ratio (INR) value > 1.5 Histological features compatible with Autoimmune hepatitis

Exclusion criteria

Exclusion criteria: All causes of acute or chronic hepatitis will be excluded Pregnant women

Design outcomes

Primary

MeasureTime frame
To assess response to steroids in patients with AIHTimepoint: To assess response to steroids in patients with AIH at day 0,3,7, 14 and 90 days after initatiation of steroids—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactHarsh Gandhi

Topiwala national medical college and BYL Nair Hospital, Mumbai

rathipmpp@gmail.com9426845977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026